The company states that it has served over 300,000 members and that clinicians have booked more than one million consultations
Patients who may benefit from discussing LDN with a Provn provider include: Those with significant needle anxiety that GLP-1 therapy would compound Those with a history of pancreatitis or other GLP-1 contraindications Those with autoimmune conditions who havent responded to conventional weight management approaches Those experiencing chronic inflammation that may contribute to metabolic difficulty Those who have tried GLP-1 therapy without success or with intolerable side effects LDN is taken as a daily oral capsule at bedtime, avoiding the storage, injection, and travel logistics associated with GLP-1 injectable therapy
Role of GLP-1 analogs in the management of diabetes and its secondary complication
Of late, multiple transcription factors such as TFAP2C, p53, AP-1, STAT, Nrf2, HIF-1, and C/EBP have been linked with the transcriptional regulation of seleno-GPxs [8, 21,22,23,24]